Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Elevated erythroferrone distinguishes erythrocytosis with inherited defects in oxygen-sensing pathway from primary familial and congenital polycythaemia

L. Sochorcova, K. Hlusickova Kapralova, J. Fialova Kucerova, D. Pospisilova, D. Prochazkova, O. Jahoda, S. Kurekova, B. Kralova, M. Divoka, J. Navratilova, J. Manakova, E. Kriegova, K. Indrak, E. Faber, V. Divoky, M. Horvathova

. 2023 ; 202 (3) : 674-685. [pub] 20230528

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016735

Congenital erythrocytoses represent a heterogenous group of rare defects of erythropoiesis characterized by elevated erythrocyte mass. We performed molecular-genetic analysis of 21 Czech patients with congenital erythrocytosis and assessed the mutual link between chronic erythrocyte overproduction and iron homoeostasis. Causative mutations in erythropoietin receptor (EPOR), hypoxia-inducible factor 2 alpha (HIF2A) or Von Hippel-Lindau (VHL) genes were detected in nine patients, including a novel p.A421Cfs*4 EPOR and a homozygous intronic c.340+770T>C VHL mutation. The association and possible cooperation of five identified missense germline EPOR or Janus kinase 2 (JAK2) variants with other genetic/non-genetic factors in erythrocytosis manifestation may involve variants of Piezo-type mechanosensitive ion channel component 1 (PIEZO1) or Ten-eleven translocation 2 (TET2), but this requires further research. In two families, hepcidin levels appeared to prevent or promote phenotypic expression of the disease. No major contribution of heterozygous haemochromatosis gene (HFE) mutations to the erythrocytic phenotype or hepcidin levels was observed in our cohort. VHL- and HIF2A-mutant erythrocytosis showed increased erythroferrone and suppressed hepcidin, whereas no overproduction of erythroferrone was detected in other patients regardless of molecular defect, age or therapy. Understanding the interplay between iron metabolism and erythropoiesis in different subgroups of congenital erythrocytosis may improve current treatment options.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016735
003      
CZ-PrNML
005      
20231026105606.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bjh.18891 $2 doi
035    __
$a (PubMed)37246471
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sochorcova, Lucie $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
245    10
$a Elevated erythroferrone distinguishes erythrocytosis with inherited defects in oxygen-sensing pathway from primary familial and congenital polycythaemia / $c L. Sochorcova, K. Hlusickova Kapralova, J. Fialova Kucerova, D. Pospisilova, D. Prochazkova, O. Jahoda, S. Kurekova, B. Kralova, M. Divoka, J. Navratilova, J. Manakova, E. Kriegova, K. Indrak, E. Faber, V. Divoky, M. Horvathova
520    9_
$a Congenital erythrocytoses represent a heterogenous group of rare defects of erythropoiesis characterized by elevated erythrocyte mass. We performed molecular-genetic analysis of 21 Czech patients with congenital erythrocytosis and assessed the mutual link between chronic erythrocyte overproduction and iron homoeostasis. Causative mutations in erythropoietin receptor (EPOR), hypoxia-inducible factor 2 alpha (HIF2A) or Von Hippel-Lindau (VHL) genes were detected in nine patients, including a novel p.A421Cfs*4 EPOR and a homozygous intronic c.340+770T>C VHL mutation. The association and possible cooperation of five identified missense germline EPOR or Janus kinase 2 (JAK2) variants with other genetic/non-genetic factors in erythrocytosis manifestation may involve variants of Piezo-type mechanosensitive ion channel component 1 (PIEZO1) or Ten-eleven translocation 2 (TET2), but this requires further research. In two families, hepcidin levels appeared to prevent or promote phenotypic expression of the disease. No major contribution of heterozygous haemochromatosis gene (HFE) mutations to the erythrocytic phenotype or hepcidin levels was observed in our cohort. VHL- and HIF2A-mutant erythrocytosis showed increased erythroferrone and suppressed hepcidin, whereas no overproduction of erythroferrone was detected in other patients regardless of molecular defect, age or therapy. Understanding the interplay between iron metabolism and erythropoiesis in different subgroups of congenital erythrocytosis may improve current treatment options.
650    _2
$a lidé $7 D006801
650    12
$a polycytemie $x genetika $7 D011086
650    _2
$a hepcidiny $x genetika $7 D064451
650    _2
$a kyslík $x metabolismus $7 D010100
650    _2
$a mutace $7 D009154
650    _2
$a receptory erythropoetinu $x genetika $7 D017467
650    _2
$a iontové kanály $x genetika $7 D007473
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hlusickova Kapralova, Katarina $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $1 https://orcid.org/0000000162352915
700    1_
$a Fialova Kucerova, Jana $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $1 https://orcid.org/0000000288089411 $7 xx0153708
700    1_
$a Pospisilova, Dagmar $u Department of Paediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Prochazkova, Daniela $u Department of Paediatrics, Faculty of Health Studies, J.E. Purkyne University, Usti nad Labem, Czech Republic
700    1_
$a Jahoda, Ondrej $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Kurekova, Simona $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Kralova, Barbora $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Divoka, Martina $u Department of Haemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Navratilova, Jana $u Department of Haemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Manakova, Jirina $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
700    1_
$a Kriegova, Eva $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $1 https://orcid.org/0000000289694197
700    1_
$a Indrak, Karel $u Department of Haemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Faber, Edgar $u Department of Haemato-Oncology, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Divoky, Vladimir $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $1 https://orcid.org/000000030202245X $7 xx0018902
700    1_
$a Horvathova, Monika $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic $1 https://orcid.org/0000000338578986 $7 ntk2011644397
773    0_
$w MED00009374 $t British journal of haematology $x 1365-2141 $g Roč. 202, č. 3 (2023), s. 674-685
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37246471 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105600 $b ABA008
999    __
$a ok $b bmc $g 2000324 $s 1203097
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 202 $c 3 $d 674-685 $e 20230528 $i 1365-2141 $m British journal of haematology $n Br J Haematol $x MED00009374
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace